Portfolio Lab

Healthpeak Properties, Inc.

  • Stock
  • Ticker DOC
  • NYSE

Real estate · REITs · USA

$19.24 +0.26%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of Healthpeak Properties, Inc. since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

DOCGlobal equities (VT)

$10,000 grew to $11,386. Global equities (VT): $29,042.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −54.1% in 10/2023, measured from the peak in 08/2021. The old peak has not been reached again yet.

1-year return
+18.0%
5-year return p.a.
−5.6%
10-year return p.a.
+1.3%
Volatility p.a.
25.4%
Largest decline
−54.1%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end12/202403/202506/202509/202512/202503/202606/202609/2026
Income statement
Revenue698703694706719753772821
Gross profit421430418414––––
Net income4.54332-1171141945317
Earnings per share0.000.060.05-0.170.160.280.080.02
Balance sheet
Total assets19,93819,81619,81019,58220,33621,61621,68022,412
Liabilities10,88110,97211,22311,31712,03412,55612,18211,607
Equity8,4018,1887,9287,5977,5007,8267,8457,866
Cash1207189914671,1711,627514
Long-term debt8,7168,8779,0419,1329,84810,42310,0329,382
Cash flow
Operating cash flow284279363315294261361354
Free cash flow284279363315294261361354

Value it:DCF calculatorMultiples calculator

Annual returns

Best year 2019 at +29.1%, weakest 2022 at −27.5%. 4 of 9 full years were positive. * partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
3 Nov 2026$0.02
5 Aug 2026$0.08
6 May 2026$0.28
3 Feb 2026$0.16
24 Oct 2025−$0.17
25 Jul 2025$0.05
25 Apr 2025$0.06
4 Feb 2025$0.00
25 Oct 2024$0.12
26 Jul 2024$0.21
26 Apr 2024$0.01
9 Feb 2024$0.13

Key metrics

Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€12bn
Market cap in trading currency
$13.3bn
Enterprise value
$22.1bn
P/E
35.6
P/S
4.33
P/B
1.69
EV/Sales
7.22
EV/EBITDA
11.7
Earnings yield
2.8%
FCF yield
9.6%

Results (last four quarters)

Revenue
$3.06bn
Gross profit
–
EBITDA
$1.89bn
Net income
$378m
Earnings per share
$0.54
Revenue per share
$4.44
Revenue growth
+16.3%
Earnings growth
–

Profitability

Gross margin
–
Operating margin
24.7%
Net margin
12.3%
Return on equity
4.9%
Return on assets
1.7%

Balance sheet and cash flow

Cash
$514m
Cash per share
$0.75
Financial debt
$9.38bn
Debt/equity %
119
Current ratio
–
Book value per share
$11.41
Operating cash flow
$1.27bn
Free cash flow
$1.27bn

Dividend

Dividend yield
6.87%
Dividend (12 months)
$1.32
Yield (12 months)
6.87%
Payout ratio
245%
Ex-dividend date
13 Nov 2026

Shares and trading

Shares outstanding
690m
Volume
6.24m
Avg. volume 3 months
5.55m
Relative volume
1.1

Price and technicals

Price
$19.24
1 day
+0.3%
52-week high
$22.82
52-week low
$15.78
Distance to 52-week high
−15.7%
Distance to 52-week low
+21.9%
Distance to 50-day line
−1.7%
Distance to 200-day line
−0.4%
RSI (14)
43
Volatility 1M
22.9%

Performance

1 week
−3.7%
1 month
−0.5%
3 months
−11.0%
6 months
−2.5%
YTD
+19.7%
1 year
+9.3%

Dates

Fiscal year end
31 Dec 2025
Most recent quarter
30 Sep 2026

Frequently asked questions

How has DOC performed since 11/2016?

$10,000 grew to $11,386 by 20 Nov 2026, which is +1.3% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is DOC?

Volatility was 25.4% per year, measured on monthly returns. The largest decline from a peak was −54.1%, with the low in 10/2023.

How does DOC compare with a broad equity ETF?

Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, DOC returned +1.3% at 25.4%. The correlation of monthly returns was 0.54; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

Healthpeak Properties, Inc. (DOC): Return and risk